ArticlePloS one2025
Intracellular lymphocyte protein biomarkers for early radiological triage in the human population.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biological effects of conventional and ultra high dose rate radiation in human cells.Scientific reports · 2026Article
- Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins.Radiation (Multidisciplinary Digital Publishing Institute) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In the event of a large-scale radiological or nuclear emergency, a rapid, high-throughput screening tool will be essential for efficient triage of potentially exposed individuals, optimizing scarce medical resources and ensuring timely care. The objective of this work was to characterize the effects of age and sex on two intracellular lymphocyte protein biomarkers, BAX and p53, for early radiation exposure classification in the human population, using an imaging flow cytometry-based platform for rapid biomarker quantification in whole blood samples. Peripheral blood samples from male and female donors, across three adult age groups (young adult, middle-aged, senior) and a juvenile cohort, were X-irradiated (0-5 Gy), and biomarker expression was quantified at two- and three-days post-exposure. Mixed-effects modeling and ensemble machine learning approaches were employed to evaluate the influence of Age and Sex on biomarker expression and develop predictive models for radiation exposure classification. Although some Age and Sex effects on biomarker expression levels were observed when the data was stratified by targeted conditions of biomarker, day, age group, and sex, these variables were ultimately not retained as significant predictors of exposure classification. A single ensemble model successfully classified radiation exposure across all tested cohorts, with ROC AUC values ranging from 0.85 to 0.95 at the 1 Gy threshold and 0.81 to 0.87 at the 2 Gy threshold, high sensitivity values (91-96%) and low false-negative rates across all classifications. These findings support the use of BAX and p53 biomarkers in a blood test for efficient triage in large-scale emergencies, excluding individuals below exposure thresholds from unnecessary medical care with minimal risk of denying care to those truly exposed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.